机构:[1]Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China[2]Department of Neurology, XuanWu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院[3]Department of Radiology, XuanWu Hospital, Capital Medical University, Beijing, China医技科室放射科首都医科大学宣武医院[4]Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China[5]Beijing Municipal Geriatric Medical Research Center, Beijing, China[6]Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, China
This work was supported by National Natural Science
Foundation (No. 82104435, Sponsor: Mingyang Wang, role:
execution and analysis), National Natural Science Foundation
(No. 82171396, Sponsor: Lihua Wang, role: study design), and
the Major Science and Technology Special Project of Yunnan
Province (No. 202102AA100061, Sponsor: Lianmei Zhong, role:
manuscript conception, planning, writing, and decision to
publish).
第一作者机构:[1]Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China[2]Department of Neurology, XuanWu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[2]Department of Neurology, XuanWu Hospital, National Center for Neurological Disorders, Capital Medical University, Beijing, China[5]Beijing Municipal Geriatric Medical Research Center, Beijing, China
推荐引用方式(GB/T 7714):
Bo Chunrui,Li Jingkai,Wang Junjie,et al.Dimethyl Fumarate Modulates the Immune Environment and Improves Prognosis in the Acute Phase after Ischemic Stroke[J].Neuroimmunomodulation.2024,31(1):126-141.doi:10.1159/000539589.
APA:
Bo Chunrui,Li Jingkai,Wang Junjie,Zhang Yaxin,Wu Tao...&Zhong Lianmei.(2024).Dimethyl Fumarate Modulates the Immune Environment and Improves Prognosis in the Acute Phase after Ischemic Stroke.Neuroimmunomodulation,31,(1)
MLA:
Bo Chunrui,et al."Dimethyl Fumarate Modulates the Immune Environment and Improves Prognosis in the Acute Phase after Ischemic Stroke".Neuroimmunomodulation 31..1(2024):126-141